A petition urges the FDA to allow certain radiology AI software updates via postmarket study requirements instead of new 510(k) applications.
Key Details
- 1Petition submitted to the FDA seeks a streamlined pathway for radiology AI software with prior 510(k) clearance.
- 2Proposal targets CADx, CADe/x, CADt, and medical image analyzer software types under specified FDA regulations.
- 3Vendors with cleared devices could forgo new 510(k) submissions for new features, provided robust postmarket measures are in place.
- 4Existing 510(k) pathway would remain as an option; the new pathway would be partially exempt under defined conditions.
- 5FDA is accepting comments on the proposal until February 27, 2026.
- 6The proposal aims to close the 'innovation gap' between the U.S. and other regions, citing more limited AI diagnostic offerings in the U.S.
Why It Matters
If adopted, this pathway could accelerate the deployment of AI innovations in U.S. radiology by reducing regulatory redundancy, addressing concerns about lagging AI adoption compared to Europe. It signals ongoing regulatory evolution in medical imaging AI oversight.
Source
AuntMinnie
Related News
•Radiology Business
Radiology AI Devices at Elevated Risk for FDA Recalls, Study Finds
Radiology AI devices are more likely to face FDA recalls, largely due to deviations from intended use and incomplete clinical data.
•AuntMinnie
ONC Official at SIIM Calls for Smarter AI and Better Image Sharing
ONC's Dr. Jason Funderburk urges improvements in medical image sharing and AI readiness at SIIM 2024.
•HealthExec
House Moves to Block AI-Driven Medicare Prior Authorization Pilot
A U.S. House committee voted to block the expansion of an AI-driven Medicare prior authorization pilot active in six states.